CME Symposia in Conjunction with the Eastern Pulmonary Conference
Sunday, January 10th, 2021
9:30 am – 11:45 am Eastern Time
Access Virtually at academiccme.com/EPChybrid or via the Eastern Pulmonary Conference at The Breakers Palm Beach
This interactive, virtual CME symposium, chaired by Dr. Sidney S. Braman, will provide learners with a comprehensive update regarding mycobacterial lung disease, non-small cell lung cancer (NSCLC) and pulmonary arterial hypertension. The expert faculty will first highlight current data for the treatment and management of mycobacterial lung disease, including diagnostic best practices. Following, the faculty will review current treatment options for patients with NSCLC, emphasizing anti-PD-1 targeted therapies. To conclude, the faculty will relay optimal clinical strategies for managing patients with pulmonary arterial hypertension, referencing recent guidelines. This CME event will be held live during the Eastern Pulmonary Conference as well as live-streamed through an interactive platform format for virtual participants.
9:30 am – 9:35 am ET: Welcome and Introductions – Sidney S. Braman, MD
9:35 am – 10:05 am ET: Advances in Nontuberculous Mycobacterial Lung Disease: Improvement in Diagnosis, Treatment and Patient Quality of Life – Charles L. Daley, MD
10:05 am – 10:15 am ET: Interactive Panel Discussion – Sidney S. Braman, MD and Expert Faculty
*Supported by an educational grant from Insmed Incorporated
10:15 am – 10:45 am ET: Update on Anti-PD-1 Targeted Therapies for the Management of Patients with NSCLC – M. Patricia Rivera, MD
10:45 am – 11:00 am ET: Interactive Panel Discussion – Sidney S. Braman, MD and Expert Faculty
*Supported by educational grants from AstraZeneca Pharmaceuticals and BeiGene, LTD
11:00 am – 11:30 am ET: Clinical Updates for the Management of Patients with Pulmonary Arterial Hypertension – James R. Klinger, MD
11:30 am – 11:45 am ET: Interactive Panel Discussion – Sidney S. Braman, MD and Expert Faculty
*Supported by an educational grant from Actelion Pharmaceuticals
Chaired by: Sidney S. Braman, MD
Advances in Nontuberculous Mycobacterial Lung Disease: Improvement in Diagnosis, Treatment and Patient Quality of Life – Charles L. Daley, MD
Update on Anti-PD-1 Targeted Therapies for the Management of Patients with NSCLC – M. Patricia Rivera, MD
Clinical Updates for the Management of Patients with Pulmonary Arterial Hypertension – James R. Klinger, MD
Disclosures of Conflict of Interest
It is the policy of AcademicCME that all faculty, instructors, and planners disclose real or apparent conflicts of interest relating to the topics of this educational activity.
The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CE activity:
|Faculty||Relationship Identified With:|
|Sidney S. Braman, MD||Consultant/Advisor: Sunovion Pharmaceuticals Inc.
Speakers Bureau: AstraZeneca Pharmaceuticals; Boehringer Ingelheim; GmbH, Inc; Genentech, Inc.
|Charles L. Daley, MD
|Consultant/Advisor: AN2; Cipla; Insmed; Matinas; Paratek; Spero
Grant/Research Support: Insmed; Spero Therapeutics
|James R. Klinger, MD||Grant/Research Support: United Therapeutics|
|M. Patricia Rivera, MD||Nothing to Disclose|
Planners and Peer Reviewers
Timothy Hayes, MD, PhD; Kim Cheramie, MSN, RN-BC; and Nicole McMenamin hereby state that they or their spouse/life partner do not have any financial relationships to products or devices with any commercial interests related to the content of this activity of any amount during the past 12 months.
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Credit Designation Statements
AcademicCME designates this live material for a maximum of 2.50 AMA PRA Category 1 CreditsTM.
Participants should claim only the credit commensurate with the extent of their participation in the activity.
CE Inquiries/Special Needs
For all CE inquiries or special needs, please contact [email protected] or 610-687-3300.
This activity has been supported by independent educational grants from Actelion Pharmaceuticals; AstraZeneca Pharmaceuticals; BeiGene, LTD and Insmed Incorporated
Virtual Event Details
There is no fee associated with tuning in to the virtual event. Pre-registration is required. Further details regarding how to tune in to the session online will be emailed to you prior to the event.
This educational activity is held in conjunction with the Eastern Pulmonary Conference. For further details and to register for the event from January 7th – 10th, 2021 at the Breaker’s in Palm Beach, Florida visit: https://easternpulmonaryconference.org/.
Provided by AcademicCME